CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Houston, TX

UT Health Mays Cancer Center 7979 Wurzbach Rd., San Antonio

This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.

Hemophilia A Grand Rounds

This case-based live activity will cover the treatment and management of patients with hemophilia A

axSpA GR – Miami, FL

This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.

CRC Grand Rounds – Newnan, GA

This live activity will cover the treatment and management of patients with refractory metastatic colorectal cancer (CRC).